OTCMKTS:TRGMTargeted Medical Pharma Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Targeted Medical Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.01 0.00 (0.00 %) (As of 08/14/2020 04:00 PM ET) Add Compare Share Today's Range$0.01Now: $0.01▼$0.0150-Day Range$0.01MA: $0.01▼$0.0252-Week Range$0.01Now: $0.01▼$0.03VolumeN/AAverage Volume27,193 shsMarket Capitalization$294,700.00P/E RatioN/ADividend YieldN/ABeta0.37 ProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workers' compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly to dispensing physician clients. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Targeted Medical Pharma. Previous Next 2.4 Community Rank Outperform VotesTargeted Medical Pharma has received 36 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTargeted Medical Pharma has received 38 “underperform” votes. (Add your “underperform” vote.)Community SentimentTargeted Medical Pharma has received 51.35% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Targeted Medical Pharma and other stocks. Vote “Outperform” if you believe TRGM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TRGM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTargeted Medical Pharma does not currently pay a dividend.Dividend GrowthTargeted Medical Pharma does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Targeted Medical Pharma insiders have not sold or bought any company stock.Percentage Held by Insiders69.20% of the stock of Targeted Medical Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.68 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TRGM Previous Symbol CUSIP876140104 CIK1420030 Webwww.targetedmedicalpharma.com Phone310-474-9809Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees30 Outstanding Shares29,470,000Market Cap$294,700.00 Next Earnings DateN/A OptionableNot Optionable $0.01 0.00 (0.00 %) (As of 08/14/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive TRGM News and Ratings via Email Sign-up to receive the latest news and ratings for TRGM and its competitors with MarketBeat's FREE daily newsletter. Targeted Medical Pharma (OTCMKTS:TRGM) Frequently Asked Questions How has Targeted Medical Pharma's stock price been impacted by COVID-19? Targeted Medical Pharma's stock was trading at $0.0094 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TRGM stock has increased by 6.4% and is now trading at $0.01. View which stocks have been most impacted by COVID-19. Has Targeted Medical Pharma been receiving favorable news coverage? News headlines about TRGM stock have been trending positive on Saturday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Targeted Medical Pharma earned a news sentiment score of 2.4 on InfoTrie's scale. They also gave news stories about the specialty pharmaceutical company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View the latest news about Targeted Medical Pharma. Who are some of Targeted Medical Pharma's key competitors? Some companies that are related to Targeted Medical Pharma include THERAPIX BIOSCI/S (TRPX), Capstone Therapeutics (CAPS), Achaogen (AKAOQ), Cotinga Pharmaceuticals (COTQF), Argos Therapeutics (ARGSQ), Spotlight Innovation (STLT), Sienna Biopharmaceuticals (SNNAQ), ProMetic Life Sciences (PFSCF), HST Global (HSTC), Sophiris Bio (SPHS), Inspyr Therapeutics (NSPX), Praxsyn (PXYN), Orexigen Therapeutics (OREXQ), Propanc Biopharma (PPCB) and Skinvisible (SKVI). View all competitors. What other stocks do shareholders of Targeted Medical Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Targeted Medical Pharma investors own include Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Biocept (BIOC), ArQule (ARQL), Arena Pharmaceuticals (ARNA), ARI Network Services (ARIS), Aoxing Pharmaceutical (AOXG), Aeolus Pharmaceuticals (AOLS), Amarin (AMRN) and American International Group (AIG). Who are Targeted Medical Pharma's key executives? Targeted Medical Pharma's management team includes the following people: Mr. Douglas P. Gintz, Chief Marketing & Technology Officer (Age 52)Mr. Kim Giffoni, Exec. VP of Foreign Sales (Age 67)Marcus Charuvastra, MD & Director What is Targeted Medical Pharma's stock symbol? Targeted Medical Pharma trades on the OTCMKTS under the ticker symbol "TRGM." How do I buy shares of Targeted Medical Pharma? Shares of TRGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Targeted Medical Pharma's stock price today? One share of TRGM stock can currently be purchased for approximately $0.01. How big of a company is Targeted Medical Pharma? Targeted Medical Pharma has a market capitalization of $294,700.00. Targeted Medical Pharma employs 30 workers across the globe. What is Targeted Medical Pharma's official website? The official website for Targeted Medical Pharma is www.targetedmedicalpharma.com. How can I contact Targeted Medical Pharma? Targeted Medical Pharma's mailing address is 2980 BEVERLY GLEN CIRCLE SUITE 301, LOS ANGELES CA, 90077. The specialty pharmaceutical company can be reached via phone at 310-474-9809 or via email at [email protected] This page was last updated on 8/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
